In vitro studies on the inhibition of colon cancer by butyrate and polyphenolic compounds

Nutrition and Cancer

Volumn 63, Issue 2, 2011, Pages 282-294

  Gonçalves, Pedro ^a   Araújo, João R ^a   Pinho, M João ^a   Martel, Fátima ^a  

^a University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID; CATECHIN; CHRYSIN; EPICATECHIN; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER 1; MYRICETIN; POLYPHENOL DERIVATIVE; QUERCETIN; RESVERATROL; XANTHOHUMOL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL VIABILITY; COLON CANCER; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATION; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; ANTICARCINOGENIC AGENTS; APOPTOSIS; BUTYRATES; CACO-2 CELLS; CATECHIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; FLAVONOIDS; HUMANS; PHENOLS; PROPIOPHENONES; QUERCETIN; REGRESSION ANALYSIS; RUTIN; STILBENES;

EID: 79951877120     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2011.523166     Document Type: Article

References (65)

1. Park Y, Hunter DJ, Spiegelman D, Bergkvist L, Berrino F, et al.: Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294, 2849-2857, 2005. (Pubitemid 41785865)
2. Martínez ME, Marshall JR, and Giovannucci E: Diet and cancer prevention: the roles of observation and experimentation. Nat Rev Cancer 8, 694-703, 2008.
3. Aron PM and Kennedy JA: Flavan-3-ols: nature, occurrence, and biological activity. Mol Nutr Food Res 52, 79-104, 2008. (Pubitemid 351211804)
4. Butt MS and Sultan MT: Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 49, 463-473, 2009.
5. Roediger WE: Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793-798, 1980.
6. Scheppach W, Bartram P, Richter A, Richter F, Liepold H, et al.: Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parenter Enteral Nutr 16, 43-48, 1992.
7. Hague A, Elder DJ, Hicks DJ, and Paraskeva C: Apoptosis in colorectal tumour cells: induction by the short-chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 60, 400-406, 1995.
8. Heerdt BG, Houston MA, and Augenlicht LH: Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 54, 3288-3293, 1994.
9. Kripke SA, Fox AD, Berman JM, Settle RG, and Rombeau JL: Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. J Parent Enter Nutr 13, 109-116, 1989. (Pubitemid 19096619)
10. Sakata T and von Engelhardt W: Stimulatory effect of short-chain fatty acids on the epithelial cell proliferation in rat large intestine. Comp Biochem Physiol 74A, 459-462, 1983. (Pubitemid 13143073)
11. Montrose MH and Kere J: Anion absorption in the intestine: anion transporters, short chain fatty acids, and role of the DRA gene product. Curr Top Membr Transp 50, 301-328, 2001.
12. Binder HJ and Mehta P: Short-chain fatty acids stimulate Na and Cl absorption in vitro in the rat distal colon. Gastroenterology 96, 989-996, 1989. (Pubitemid 19091111)
13. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, and Brummer RJ: Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104-119, 2008. (Pubitemid 350256609)
14. Wong JM, de Souza R, Kendall CW, Emam A, and Jenkins DJ: Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235-243, 2006. (Pubitemid 44309560)
15. Gibson PR, Rosella O, Wilson AJ, Mariadason JM, Rickard K, et al.: Colonic epithelial cell activation and the paradoxical effects of butyrate. Carcinogenesis 20, 539-544, 1999. (Pubitemid 29151287)
16. Daly K and Shirazi-Beechey SP: Microarray analysis of butyrate regulated genes in colonic epithelial cells. DNA Cell Biol 25, 49-62, 2006. (Pubitemid 43089752)
17. Hinnebusch BF, Meng S, Wu JT, Archer SY, and Hodin RA: The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132, 1012-1017, 2002. (Pubitemid 34493567)
18. Morris ME and Felmlee MA: Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid. AAPS J 10, 311-321, 2008.
19. Halestrap AP and Meredith D: The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch-Eur J Physiol 447, 619-628, 2004. (Pubitemid 38241446)
20. Gupta N, Martin PM, Prasad PD, and Ganapathy V: SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci 78, 2419-2425, 2006.
21. Cuff M, Dyer J, Jones M, and Shirazi-Beechey S: The human colonic monocarboxylate transporter isoform 1: its potential importance to colonic tissue homeostasis. Gastroenterology 128, 676-686, 2005. (Pubitemid 40585370)
22. Shim CK, Cheon EP, Kang KW, Seo KS, and Han HK: Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells. J Pharm Pharmacol 59, 1515-1519, 2007.
23. Wang Q and Morris ME: Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos 35, 201-208, 2007. (Pubitemid 46151668)
24. Konishi Y, Kobayashi S, and Shimizu M: Tea polyphenols inhibit the transport of dietary phenolic acids mediated by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. J Agric Food Chem 51, 7296-7302, 2003.
25. Vaidyanathan JB and Walle T: Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 307, 745-752, 2003. (Pubitemid 37310692)
26. Belt JA, Thomas JA, Buchsbaum RN, and Racker E: Inhibition of lactate transport and glycolysis in Ehrlich ascites tumor cells by bioflavonoids. Biochemistry 18, 3506-3511, 1979. (Pubitemid 9255089)
27. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63, 1983.
28. Thibault R, De Coppet P, Daly K, Bourreille A, Cuff M, et al.: Downregulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 133, 1916-1927, 2007.
29. Marsman KE and McBurney MI: Dietary fiber increases oxidative metabolism in colonocytes but not in distal small intestinal enterocytes isolated from rats. J Nutr 125, 273-282, 1995.
30. Negrão MR, Keating E, Faria A, Azevedo I, and Martins MJ: Acute effect of tea, wine, beer, and polyphenols on ecto-alkaline phosphatase activity in human vascular smooth muscle cells. J Agric Food Chem 54, 4982-4988, 2006. (Pubitemid 44140892)
31. Bergmeyer HU and Bernt E: Lactate dehydrogenase. In:Methods in Enzymatic Analysis , Bergmeyer HU (ed.). New York, Academic Press, 1974, pp. 574-579.
32. Bradford MM: A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254, 1976.
33. Muzyka A, Tarkany O, Yelizanof V, Sergienko U, and Boichuk A: Non-Linear Regression (Curve Fit). San Diego, CA, GraphPad Prism for Windows, 2005.
34. Gonçalves P, Araújo JR, Pinho MJ, and Martel F: Modulation of butyrate transport in Caco-2 cells. Naunyn-Schmiedeberg's Arch Pharmacol 379, 325-336, 2009.
35. Cuff MA and Shirazi-Beechey SP: The importance of butyrate transport to the regulation of gene expression in the colonic epithelium. Biochem Soc Trans 32, 1100-1102, 2004. (Pubitemid 39655558)
36. Cuff MA, Lambert DW, and Shirazi-Beechey SP: Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J Physiol 539, 361-371, 2002. (Pubitemid 35175393)
37. Buyse M, Sitaraman SV, Liu X, Bado A, and Merlin D: Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE. J Biol Chem 277, 28182-28190, 2002. (Pubitemid 34966772)
38. Alrefai WA, Tyagi S, Gill R, Saksena S, Hadjiagapiou C, et al.: Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate. Am J Physiol Gastrointest Liver Physiol 286, G197-G203, 2004. (Pubitemid 38134030)
39. Borthakur A, Gill RK, Hodges K, Ramaswamy K, Hecht G, and Dudeja PK: Enteropathogenic escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am J Physiol Gastrointest Liver Physiol 290, G30-G35, 2006.
40. German JB and Walzem RL: The health benefits of wine. Annu Rev Nutr 20, 561-593, 2000.
41. Middleton Jr E, Kandaswami C, and Theoharides TC: The effects of plant flavonoids on mammalian cells: implication for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673-751, 2000.
42. Keating E, Lemos C, Azevedo I, and Martel F: Characteristics of thiamine uptake by the BeWo human trophoblast cell line. J Biochem Mol Biol 39, 383-393, 2006. (Pubitemid 44371866)
43. Lemos C, Peters GJ, Jansen G, Martel F, and Calhau C: Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur J Nutr 46, 329-336, 2007. (Pubitemid 47353607)
44. Araújo JR Gonçalves P, and Martel F: Modulation of glucose uptake in a human trophoblast cell line (BeWo) by dietary bioactive compounds and drugs of abuse. J Biochem 144, 177-186, 2008.
45. Keating E, Lemos C, Gonçalves P, Azevedo I, and Martel F: Acute and chronic effects of some dietary bioactive compounds on folic acid uptake and on the expression of folic acid transporters by the human trophoblast cell line BeWo. J Nutr Biochem 19, 91-100, 2008.
46. Chen C, Shen G, Hebbar V, Hu R, Owuor ED, and Kong AN: Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 24, 1369-1378, 2003. (Pubitemid 37045317)
47. Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, et al.: Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis. Anticancer Res 23, 1533-1539, 2003. (Pubitemid 36754125)
48. Ranelletti FO, Ricci R, Larocca LM, Maggiano N, Capelli A, et al.: Growth inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer 50, 486-492, 1992.
49. Jeong W-S, Kim I-W, Hu R, and Kong A-NT: Modulatory properties of various natural chemopreventive agents on the activation of NF-κB signaling pathway. Pharm Res 21, 661-670, 2004. (Pubitemid 38457289)
50. Wenzel U, Herzog A, Kuntz S, and Daniel H: Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 4, 2160-2174, 2004. (Pubitemid 38880380)
51. Leone M, Zhai D, Sareth S, Kitada S, Reed JC, Pellecchia M: Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 63, 8118-8121, 2003. (Pubitemid 37549456)
52. Dihal AA, de Boer VC, Van Der Woude H, Tilburgs C, Bruijntjes JP et al. : Quercetin, but not its glycosidated conjugate rutin, inhibits azoxymethane-induced colorectal carcinogenesis in F344 rats. J Nutr 136, 2862-2867, 2006. (Pubitemid 44771787)
53. Tanaka T, Kawabata K, Honjo S, Kohno H, Murakami M, et al.: Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncol Rep 6, 1333-1340, 1999.
54. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, et al.: Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 21, 1655-1660, 2000.
55. Deschner EE, Ruperto JF, Wong GY, and Newmark HL: The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr Cancer 20, 199-204, 1993. (Pubitemid 23350020)
56. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, et al.: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21, 921-927, 2000. (Pubitemid 30265135)
57. Matsukawa Y, Nishino H, Okuyama Y, Matsui T, Matsumoto T, et al.: Effects of quercetin and/or restraint stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. Oncology 54, 118-121, 1997. (Pubitemid 27101758)
58. Wang W, Van Alstyne PC, Irons KA, Chen S, Stewart JW, and Birt DF: Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutr Cancer 48, 106-114, 2004. (Pubitemid 38823552)
59. Miyamoto S, Kohno H, Suzuki R, Sugie S, Murakami A, et al.: Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Oncol Rep 15, 1169-1173, 2006.
60. Van Der Woude H, Gliszczyńska-Swigło A, Struijs K, Smeets A, Alink GM, and Rietjens IM: Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett 200, 41-47, 2003. (Pubitemid 37222357)
61. Mariadason JM, Velcich A, Wilson AJ, Augenlicht LH, and Gibson PR: Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120, 889-899, 2001. (Pubitemid 32193186)
62. Fu H, Shi YQ, and Mo SJ: Effect of short-chain fatty acids on the proliferation and differentiation of the human colonic adenocarcinoma cell line Caco-2. Chin J Dig Dis 5, 115-117, 2004. (Pubitemid 39199626)
63. Bock KW, Eckle T, Ouzzine M, and Fournel-Gigleux S: Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochem Pharmacol 59, 467-470, 2000. (Pubitemid 30045584)
64. Lohner K, Schnäbele K, Daniel H, Oesterle D, Rechkemmer G, Göttlicher M, and Wenzel U: Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo. Mol Nutr Food Res 51, 293-300, 2007. (Pubitemid 47083663)
65. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, and Zucco F: The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 21, 1-26, 2005. (Pubitemid 40767684)